These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23172277)

  • 1. [A survey of actual clinical application patterns in Korean diagnostic guidelines for inflammatory bowel disease].
    Park SJ; Cheon JH; Ye BD; Choi CH; Kim YS; Kim YH; Kim JS; Jeen YT; Park YS; Han DS; Yang SK; Kim WH
    Korean J Gastroenterol; 2012 Nov; 60(5):292-9. PubMed ID: 23172277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
    Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
    Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
    BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.
    Sung JJ; Kamm MA; Marteau P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):183-93. PubMed ID: 19929931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom.
    Tsironi E; Feakins RM; Probert CS; Rampton DS; Phil D
    Am J Gastroenterol; 2004 Sep; 99(9):1749-55. PubMed ID: 15330914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey.
    Bronsky J; de Ridder L; Ruemmele FM; Griffiths A; Buderus S; Hradsky O; Hauer AC
    J Pediatr Gastroenterol Nutr; 2019 May; 68(5):676-683. PubMed ID: 30664566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.
    Esmat S; El Nady M; Elfekki M; Elsherif Y; Naga M
    World J Gastroenterol; 2014 Jan; 20(3):814-21. PubMed ID: 24574754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.
    Kim SH; Park Y; Kim SP; Lee SH; Oh SH; Yang SK; Yoon HJ; Kim KM
    Dig Dis Sci; 2022 Nov; 67(11):5079-5089. PubMed ID: 35094250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.
    He K; Yan X; Wu D
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up of pediatric inflammatory bowel disease].
    Guan DX; Qiu XH; Ding ZL; Wang DY; Xu XW
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1984-7. PubMed ID: 22944275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.